secwatch.observer — SEC 8-K summary
======================================

Issuer:     Damora Therapeutics, Inc. (DMRA)
CIK:        0001800315
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0000950170-23-007228
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Galecto discloses SVB exposure under $1.5M; no material impact expected
-----------------------------------------------------------------------

- FDIC took control of Silicon Valley Bank on March 10, 2023 due to liquidity concerns.
- Galecto's cash deposits at SVB total less than $1.5 million, excluding FDIC-insured amounts.
- Company does not anticipate any material effect on its operating plan or cash runway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800315/000095017023007228/0000950170-23-007228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800315/000095017023007228/glto-20230310.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer